Welltower  logo
Welltower WELL
$ 187.59 0.04%

Quarterly report 2025-Q2
added 07-29-2025

report update icon

Welltower Income Statement 2011-2025 | WELL

Annual Income Statement Welltower

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

88.7 B 48.2 B 35.4 B 35.1 B 27.1 B 34.3 B 28.6 B 21.5 B 23.8 B 21.7 B 25.1 B 15.8 B 14.1 B 9.87 B

Shares

603 M 516 M 462 M 425 M 415 M 402 M 374 M 367 M 358 M 348 M 306 M 277 M 224 M 174 M

Historical Prices

147 93.4 76.6 82.7 65.3 68.7 65.3 43.6 55.5 47.9 55.2 40 41.7 33.6

Net Income

973 M 358 M 161 M 374 M 1.04 B 1.23 B 805 M 523 M 1.08 B 884 M 512 M 145 M 297 M 218 M

Revenue

7.99 B 6.64 B 5.86 B 4.74 B 4.61 B 5.1 B 4.67 B 4.3 B 4.25 B 3.84 B 3.34 B 2.88 B 1.82 B 1.42 B

Cost of Revenue

4.83 B 3.95 B 3.56 B 2.77 B 2.6 B 2.69 B 2.43 B 2.08 B - - - - - -

Gross Profit

- - - - - 1.85 B 1.71 B 1.73 B 1.85 B 1.73 B 1.45 B 1.21 B 880 M 1.04 B

Interest Expense

- - - -41.7 M -70.3 M -52.6 M -113 M - - - - - - -

EBITDA

1.63 B 1.4 B 1.31 B 1.04 B 1.04 B 1.71 B 1.59 B 1.55 B 1.69 B 1.58 B 1.31 B 1.1 B 755 M 892 M

Operating Expenses

- - - - - 1.17 B 1.08 B 1.11 B 1.07 B 974 M 987 M 976 M 640 M 568 M

General and Administrative Expenses

235 M 179 M 150 M 127 M 128 M 127 M 126 M 122 M 155 M 147 M 143 M 108 M 97.3 M -

All numbers in USD currency

Quarterly Income Statement Welltower

2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

657 M 643 M 635 M 611 M 601 M 574 M 564 M 522 M 499 M 492 M 491 M 463 M 454 M 447 M 447 M 428 M 417 M 417 M 417 M 417 M 417 M 410 M 410 M 405 M 405 M 391 M 384 M 373 M 372 M 371 M 372 M 369 M 367 M 363 M 363 M 359 M 357 M 355 M 355 M 352 M 350 M 337 M 329 M 311 M 296 M 290 K 290 M 286 M 273 M 260 M 260 M 224 M 213 M 200 M 192 M 177 M 176 M 155 M

Net Income

305 M 257 M - 457 M 261 M 132 M - 135 M 106 M 28.6 M - -2.65 M 95.7 M 65.8 M - 190 M 45.8 M 72.2 M 164 M 395 M 159 M 329 M 224 M 648 M 150 M 292 M 102 M 84.2 M 167 M 454 M -112 M 89.3 M 203 M 338 M 333 M 355 M 211 M 165 M 133 M 199 M 330 M 209 M 189 M 153 M 87.9 M 65.2 M 11.5 M 33.6 M 7.18 M 71.8 M 90.6 M 53.9 M 77.7 M 58.5 M 27.3 M 53.8 M 87.2 M 32.1 M

Revenue

2.55 B 2.42 B - 2.06 B 1.82 B 1.86 B - 1.66 B 1.67 B 1.56 B - 1.47 B 1.47 B 1.4 B - 1.24 B 1.14 B 1.05 B 1.12 B 1.04 B 1.19 B 1.26 B 1.26 B 1.27 B 1.32 B 1.27 B 1.24 B 1.24 B 1.13 B 14.6 M 1.1 B 20.2 M 20.9 M 20.7 M 1.08 B 25.1 M 24 M 25.2 M - 22.4 M 20.6 M 17 M - 9.34 M 8.93 M 8.59 M - 7.63 M 7.64 M 9.06 M - 8.11 M 7.88 M 8.14 M - 7.86 M 12.9 M 11.7 M

Cost of Revenue

1.51 B 1.46 B - 1.21 B 1.11 B 1.1 B - 995 M 959 M 958 M - 912 M 854 M 854 M - 729 M 643 M 617 M - 635 M 661 M 682 M - 656 M 701 M 671 M - 657 M 569 M 556 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - -20.2 M -48.7 M -14.1 M - -38.2 M -11.1 M -22.7 M - -15.5 M -35.2 M -26.1 M - -3.58 M -11.7 M -11 M - -11.5 M -19.4 M -6.29 M - -6.19 M -21.6 M -8.76 M - -88.6 M -10.1 M -3.71 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

495 M 486 M - 404 M 382 M 366 M - 339 M 342 M 339 M - 354 M 310 M 304 M - 268 M 241 M 244 M - 256 M 265 M 275 M - 272 M 248 M 244 M - 708 M 464 M 228 M - 683 M 453 M 228 M - 673 M 455 M 229 M - 603 M 398 M 189 M - 649 M 448 M 233 M - 631 M 388 M 187 M - 393 M 260 M 127 M - 301 M 186 M 74.8 M

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - 1.19 B 1.16 B 1.14 B - 1.18 B 967 M 978 M - 1.01 B 902 M 943 M - 885 M 866 M 879 M - 782 M 806 M 729 M - 732 M 739 M 729 M - 752 M 635 M 642 M - 424 M 407 M 372 M - 326 M 322 M 245 M

General and Administrative Expenses

64.2 M 63.8 M - 77.9 M 55.6 M 53.3 M - 46.1 M 44.3 M 44.4 M - 34.8 M 36.6 M 37.7 M - 32.3 M 31.4 M 29.9 M - 31 M 34.1 M 35.5 M - 31 M 33.7 M 35.3 M - 28.7 M 32.8 M 33.7 M - 29.9 M 32.6 M 31.1 M - 36.8 M 39.9 M 45.7 M - 37 M 38.5 M 35.1 M - 30.8 M 51.7 M 32.9 M - 28.7 M 23.9 M 27.2 M - 23.7 M 25.9 M 27.8 M - 19.7 M 19.6 M 17.7 M

All numbers in USD currency

The income statement is one of the three key financial reports of a company Welltower (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Reit healthcare industry

Issuer Price % 24h Market Cap Country
The GEO Group The GEO Group
GEO
$ 16.31 -1.27 % $ 2.14 B usaUSA
LTC Properties LTC Properties
LTC
$ 34.24 0.01 % $ 1.5 B usaUSA
Global Medical REIT Global Medical REIT
GMRE
$ 33.37 1.21 % $ 2.2 B usaUSA
National Health Investors National Health Investors
NHI
$ 77.01 0.26 % $ 3.38 B usaUSA
Omega Healthcare Investors Omega Healthcare Investors
OHI
$ 44.37 0.25 % $ 11.5 B usaUSA
Healthpeak Properties Healthpeak Properties
PEAK
- 2.09 % $ 9.35 B usaUSA
Sabra Health Care REIT Sabra Health Care REIT
SBRA
$ 18.78 0.59 % $ 4.39 B usaUSA
Ventas Ventas
VTR
$ 79.61 0.13 % $ 32.8 B usaUSA